Joseph F Dasta

Summary

Affiliation: The Ohio State University
Country: USA

Publications

  1. ncbi Critical care therapeutics: a frontier for clinical pharmacy. 1982
    Joseph F Dasta
    College of Pharmacy, and Assistant Professor, Department of Anesthesiology, College of Medicine, The Ohio State University, 500 W. 12th Ave, Columbus, OH 43210, USA
    Ann Pharmacother 40:740-1. 2006
  2. ncbi Amphotericin B lipid complex for Hansenula anomala pneumonia
    Sandra L Kane
    College of Pharmacy, Ohio State University, 500 W 12th Ave, Columbus, OH 43210, USA
    Ann Pharmacother 36:59-62. 2002
  3. ncbi Critical care
    Joseph F Dasta
    College of Pharmacy, The Ohio State University, 500 W 12th Ave, Columbus, OH 43210 1291, USA
    Ann Pharmacother 40:736-7. 2006
  4. ncbi Impact of drotrecogin alfa (activated) on resource use and implications for reimbursement
    Joseph F Dasta
    College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA
    Pharmacotherapy 22:216S-222S. 2002
  5. ncbi Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data
    Joseph F Dasta
    College of Pharmacy, The Ohio State University, Columbus, OH 43210 1291, USA
    Ann Pharmacother 38:1130-5. 2004
  6. ncbi A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit
    Joseph F Dasta
    Ohio State University, USA
    Crit Care Med 38:497-503. 2010
  7. ncbi Update on tolvaptan for the treatment of hyponatremia
    Joseph F Dasta
    College of Pharmacy, The Ohio State University, Columbus, USA
    Expert Rev Pharmacoecon Outcomes Res 12:399-410. 2012
  8. ncbi A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients
    Anthony T Gerlach
    Department of Pharmacy, The Ohio State University Medical Center, Columbus, Ohio 43210, USA
    J Crit Care 24:568-74. 2009
  9. ncbi Costs and outcomes of acute kidney injury (AKI) following cardiac surgery
    Joseph F Dasta
    College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA
    Nephrol Dial Transplant 23:1970-4. 2008
  10. ncbi International critical care hospital pharmacist activities
    Jaclyn M LeBlanc
    College of Pharmacy, The Ohio State University, 500 West 12th Ave, Columbus, OH 43210, USA
    Intensive Care Med 34:538-42. 2008

Detail Information

Publications36

  1. ncbi Critical care therapeutics: a frontier for clinical pharmacy. 1982
    Joseph F Dasta
    College of Pharmacy, and Assistant Professor, Department of Anesthesiology, College of Medicine, The Ohio State University, 500 W. 12th Ave, Columbus, OH 43210, USA
    Ann Pharmacother 40:740-1. 2006
  2. ncbi Amphotericin B lipid complex for Hansenula anomala pneumonia
    Sandra L Kane
    College of Pharmacy, Ohio State University, 500 W 12th Ave, Columbus, OH 43210, USA
    Ann Pharmacother 36:59-62. 2002
    ..To document the first successful treatment of a patient with Hansenula anomala pneumonia...
  3. ncbi Critical care
    Joseph F Dasta
    College of Pharmacy, The Ohio State University, 500 W 12th Ave, Columbus, OH 43210 1291, USA
    Ann Pharmacother 40:736-7. 2006
    ....
  4. ncbi Impact of drotrecogin alfa (activated) on resource use and implications for reimbursement
    Joseph F Dasta
    College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA
    Pharmacotherapy 22:216S-222S. 2002
    ..Clinicians and administrators should work collaboratively to optimize the therapy of patients with severe sepsis, minimize the financial impact on the health care system, and maximize the utility of drotrecogin alfa (activated)...
  5. ncbi Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data
    Joseph F Dasta
    College of Pharmacy, The Ohio State University, Columbus, OH 43210 1291, USA
    Ann Pharmacother 38:1130-5. 2004
    ..In clinical practice, new drugs may be used differently than the product labeling recommends. Furthermore, it often takes several years of use before adverse drug reactions (ADRs) are reported...
  6. ncbi A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit
    Joseph F Dasta
    Ohio State University, USA
    Crit Care Med 38:497-503. 2010
    ..To compare the intensive care unit costs and determine factors influencing these costs in mechanically ventilated patients randomized to dexmedetomidine or midazolam by continuous infusion...
  7. ncbi Update on tolvaptan for the treatment of hyponatremia
    Joseph F Dasta
    College of Pharmacy, The Ohio State University, Columbus, USA
    Expert Rev Pharmacoecon Outcomes Res 12:399-410. 2012
    ....
  8. ncbi A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients
    Anthony T Gerlach
    Department of Pharmacy, The Ohio State University Medical Center, Columbus, Ohio 43210, USA
    J Crit Care 24:568-74. 2009
    ..We evaluated occurrence of hypotension and bradycardia in critically ill surgical patients receiving dexmedetomidine before and after implementation of a dosing protocol...
  9. ncbi Costs and outcomes of acute kidney injury (AKI) following cardiac surgery
    Joseph F Dasta
    College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA
    Nephrol Dial Transplant 23:1970-4. 2008
    ..We determined costs, resource use and mortality rate of patients. We used the serum creatinine component of the RIFLE system to classify AKI...
  10. ncbi International critical care hospital pharmacist activities
    Jaclyn M LeBlanc
    College of Pharmacy, The Ohio State University, 500 West 12th Ave, Columbus, OH 43210, USA
    Intensive Care Med 34:538-42. 2008
    ..The objective of this study was to describe the duties and activities of international pharmacists who practice in critical care...
  11. ncbi An updated focused review of dexmedetomidine in adults
    Anthony T Gerlach
    Ohio State University Medical Center and Ohio State University, Columbus, OH, USA
    Ann Pharmacother 43:2064-74. 2009
    ..To evaluate recent comparative studies regarding the safety and efficacy of dexmedetomidine in adults...
  12. ncbi Pharmacoeconomics of sedation in the ICU
    Joseph F Dasta
    The Ohio State University, College of Pharmacy, Columbus, OH, USA
    Crit Care Clin 25:571-83, ix. 2009
    ..Clinicians should look beyond the acquisition cost of a sedative and include the effect of sedatives on the cost of care when selecting the most appropriate sedative...
  13. ncbi Acute renal failure in hospitalized patients: part I
    Maria C Pruchnicki
    Division of Pharmacy Practice and Administration, College of Pharmacy, The Ohio State University, Columbus, OH 43210 1291, USA
    Ann Pharmacother 36:1261-7. 2002
    ..Acute renal failure (ARF) is a common condition in hospitalized patients. Morbidity, mortality, and health resource use are considerable, but the true magnitude of the problem is not well described in the literature...
  14. ncbi Acute renal failure in hospitalized patients: part II
    Maria C Pruchnicki
    Division of Pharmacy Practice and Administration, College of Pharmacy, The Ohio State University, Columbus, OH 43210 1291, USA
    Ann Pharmacother 36:1430-42. 2002
    ..Acute renal failure (ARF) is a common condition in hospitalized patients. Research has been unable to identify the optimal target for therapeutic intervention; hence, effective prevention of and/or treatment for ARF remain elusive...
  15. ncbi Role of the bispectral index in sedation monitoring in the ICU
    Jaclyn M LeBlanc
    College of Pharmacy, The Ohio State University, Columbus, 43210, USA
    Ann Pharmacother 40:490-500. 2006
    ..We recommend that further studies be conducted to determine the optimal method of obtaining BIS data and evaluate the impact of the BIS on relevant patient outcomes...
  16. ncbi Survey of hospital pharmacist activities outside of the United States
    Jaclyn M LeBlanc
    College of Pharmacy, University of Oklahoma, Tulsa, OK 74135, USA
    Am J Health Syst Pharm 64:1748-55. 2007
  17. ncbi Dexmedetomidine: an updated review
    Anthony T Gerlach
    The Ohio State University Medical Center, The Ohio State University, Columbus, OH, USA
    Ann Pharmacother 41:245-52. 2007
    ..To review recent literature on the safety and efficacy of dexmedetomidine...
  18. ncbi Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials
    Joseph F Dasta
    Professor Emeritus, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA
    Hosp Pract (1995) 40:7-14. 2012
    ....
  19. ncbi Addition of dexmedetomidine to standard sedation regimens after cardiac surgery: an outcomes analysis
    Joseph F Dasta
    College of Pharmacy, The Ohio State University, Columbus, Ohio 43210-1291, and the Department of Pharmacy, Clarian Health, Indianapolis, IN, USA
    Pharmacotherapy 26:798-805. 2006
    ....
  20. ncbi An instructional seminar for online case-based discussions
    Jaclyn M LeBlanc
    College of Pharmacy, The Ohio State University, USA
    Am J Pharm Educ 71:42. 2007
    ..To assess a training seminar developed to prepare pharmacy instructors to facilitate online discussions...
  21. ncbi Pharmacoeconomics of sedation in the ICU
    Joseph F Dasta
    The Ohio State University, College of Pharmacy, Columbus, OH, USA University of Texas, College of Pharmacy, Austin, TX, USA PO Box 967, Hutto, TX 78634 0967, USA
    Anesthesiol Clin 29:707-20. 2011
    ..Clinicians should look beyond the acquisition cost of a sedative and include the effect of sedatives on the cost of care when selecting the most appropriate sedative...
  22. ncbi Impact of disease states on the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors
    Jaclyn M LeBlanc
    College of Pharmacy, The Ohio State University, Columbus, Ohio, USA
    J Clin Pharmacol 46:968-80. 2006
    ..ACE inhibitor dosing for hypertension is reasonable based on pharmacokinetics and EC50 values. Further individualization of therapy may improve outcomes, and using the threshold AUC/EC50 ratio may help guide appropriate dosing...
  23. ncbi Intravenous to oral conversion of antihypertensives: a toolkit for guideline development
    Joseph F Dasta
    The Ohio State University, Columbus, OH, USA
    Ann Pharmacother 44:1430-47. 2010
    ..To provide a toolkit of information for hospitals to use in developing intravenous to oral conversion protocols for antihypertensives...
  24. ncbi Scope of international hospital pharmacy practice
    Jaclyn M LeBlanc
    College of Pharmacy, The Ohio State University, Columbus, OH 43210-1291, USA
    Ann Pharmacother 39:183-91. 2005
    ....
  25. ncbi Daily cost of an intensive care unit day: the contribution of mechanical ventilation
    Joseph F Dasta
    The Ohio State University, Columbus, OH, USA
    Crit Care Med 33:1266-71. 2005
    ..Interventions that result in reduced intensive care unit length of stay and/or duration of mechanical ventilation could lead to substantial reductions in total inpatient cost...
  26. ncbi Clinical outcomes of critical illness polyneuropathy
    Sandra L Kane
    School of Pharmacy, University of Pittsburgh, Pennsylvania 15261, USA
    Pharmacotherapy 22:373-9. 2002
    ..The association of CIP with sepsis, multiorgan failure, and drugs is still unclear...
  27. ncbi Characteristics, drug therapy, and outcomes from a database of 500,000 hospitalized patients with a discharge diagnosis of heart failure
    Tien M H Ng
    University of Southern California, School of Pharmacy, Los Angeles, CA 90033, USA
    Congest Heart Fail 14:202-10. 2008
    ..HF commonly exists in hospitalized patients and is associated with significant morbidity, mortality, and economic burden, irrespective of whether it is the primary diagnosis or a secondary comorbidity...
  28. ncbi Propofol associated with a shorter duration of mechanical ventilation than scheduled intermittent lorazepam: a database analysis using Project IMPACT
    Jeffrey J Fong
    School of Pharmacy, Northeastern University, Boston, MA 02115, USA
    Ann Pharmacother 41:1986-91. 2007
    ....
  29. ncbi Bispectral index does not correlate with the stress response in critical care patients
    Jaclyn M LeBlanc
    Anesth Analg 104:1616. 2007
  30. ncbi Contemporary issues in the pharmacologic management of acute heart failure
    Tien M H Ng
    Department of Pharmacy, University of Southern California, 1985 Zonal Avenue, Los Angeles, CA 90033, USA
    Crit Care Clin 22:199-219, v. 2006
    ..Clinicians should understand the rationale for use and limitations of each therapy to maximize benefit and cost-effectiveness, while minimizing the potential for adverse outcomes...
  31. ncbi Critical care pharmacy services in United States hospitals
    Robert MacLaren
    Department of Clinical Pharmacy, School of Pharmacy, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Ann Pharmacother 40:612-8. 2006
    ..Critical care pharmacy activities have been described as fundamental, desirable, and optimal, but actual services provided have not been evaluated...
  32. ncbi Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update
    Steven M Hollenberg
    Crit Care Med 32:1928-48. 2004
    ..Using this approach, specific recommendations for fluid resuscitation, vasopressor therapy, and inotropic therapy of septic in adult patients were promulgated...
  33. ncbi Intensive insulin therapy for critically ill patients
    Kelly S Lewis
    Associate Professor of Anesthesiology, Division of Critical Care, Rush Presbyterian St Luke's Medical Center, Chicago, IL, USA
    Ann Pharmacother 38:1243-51. 2004
    ..Frequent monitoring is imperative to avoid hypoglycemia...
  34. ncbi Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing ICU pharmacotherapy
    Robert J Weber
    Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15213, USA
    Crit Care Med 31:S17-24. 2003
    ..CONCLUSIONS: ICU drug therapies have a significant impact on hospital costs, and effective clinical informatics services and multidisciplinary collaboration programs are necessary to optimize ICU pharmacotherapy...
  35. ncbi Managing anemia in the critically ill patient
    Maria I Rudis
    Department of Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California 90033, USA
    Pharmacotherapy 24:229-47. 2004
    ..Patient selection for erythropoietic agents will depend on further work dealing with outcomes and the total cost of care in managing the anemia of critical illness...
  36. ncbi The impact of critical care pharmacists on enhancing patient outcomes
    Sandra L Kane
    School of Pharmacy, University of Pittsburgh, 3501 Terrace Street, Pittsburgh, PA 15261, USA
    Intensive Care Med 29:691-8. 2003
    ..Furthermore, economic evaluations of clinical pharmacy services in the ICU consistently reveal the potential for considerable cost savings...